Because they originated from a protein belonging to the innate immune response of mammals, the Lf-derived peptides are suggested to be safe for administration in humans, which constitutes an advantage when proposing them as therapy to treat amoebiasis and other microbial infections. Here, LTF is linked to amebiasis.